Last reviewed · How we verify
Iron Glycinate — Competitive Intelligence Brief
marketed
Metabolic
Live · refreshed every 30 min
Target snapshot
Iron Glycinate (FERROUS BISGLYCINATE). Iron Glycinate works by providing the body with a readily available form of iron that can be easily absorbed and utilized to produce hemoglobin.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Iron Glycinate TARGET | FERROUS BISGLYCINATE | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Iron Glycinate CI watch — RSS
- Iron Glycinate CI watch — Atom
- Iron Glycinate CI watch — JSON
- Iron Glycinate alone — RSS
Cite this brief
Drug Landscape (2026). Iron Glycinate — Competitive Intelligence Brief. https://druglandscape.com/ci/ferrous-bisglycinate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab